FORMATION OF CLASSICAL C3-CONVERTASE DURING ACTIVATION OF ALTERNATIVE PATHWAY OF HUMAN-COMPLEMENT

被引：0

|

作者：

KOSLOV, LV

SHIBANOVA, ED

ZINCHENKO, AA

机构：

来源：

BIOCHEMISTRY-MOSCOW | 1987年 / 52卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：568 / 573

页数：6

相关论文

共 50 条

[31] SCHISTOSOMA-MANSONI - ACTIVATION OF THE ALTERNATIVE PATHWAY OF HUMAN-COMPLEMENT BY SCHISTOSOMULA
DIASDASILVA, W
KAZATCHKINE, MD
EXPERIMENTAL PARASITOLOGY, 1980, 50 (02) : 278 - 286
[32] ALTERNATIVE COMPLEMENT PATHWAY ACTIVATION BY C4B DEPOSITED DURING CLASSICAL PATHWAY ACTIVATION
MATSUSHITA, M
OKADA, H
JOURNAL OF IMMUNOLOGY, 1986, 136 (08): : 2994 - 2998
[33] MURINE MEMBRANE INHIBITOR OF COMPLEMENT WHICH ACCELERATES DECAY OF HUMAN C3-CONVERTASE
KAMEYOSHI, Y
MATSUSHITA, M
OKADA, H
IMMUNOLOGY, 1989, 68 (04) : 439 - 444
[34] CR2-dependent activation of the alternative pathway of complement: Efficacy of the CR2-associated initial C3-convertase iC3BbP
Schwendinger, MG
Dierich, MP
Prodinger, WM
MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 393 - 393
[35] THE EFFECTS OF IODINE AND THIOL-BLOCKING REAGENTS ON COMPLEMENT COMPONENT-C2 AND ON THE ASSEMBLY OF THE CLASSICAL-PATHWAY C3-CONVERTASE
KERR, MA
PARKES, C
BIOCHEMICAL JOURNAL, 1984, 219 (02) : 391 - 399
[36] Stability of C3 convertase in the rat classical complement pathway
Naito, A
Okada, H
MICROBIOLOGY AND IMMUNOLOGY, 1997, 41 (08) : 621 - 624
[37] Formation of high affinity C5 convertase of the classical pathway of complement
Rawal, N
Pangburn, MK
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) : 38476 - 38483
[38] REGULATION OF THE ALTERNATIVE PATHWAY OF HUMAN-COMPLEMENT BY CLQ
FISHELSON, Z
MULLEREBERHARD, HJ
MOLECULAR IMMUNOLOGY, 1987, 24 (09) : 987 - 993
[39] INHIBITION OF CLEAVAGE OF THE 3RD COMPONENT OF HUMAN-COMPLEMENT (C3)BY ITS SMALL CLEAVAGE FRAGMENT, C3A - INHIBITION OCCURS WITH THE CLASSICAL-PATHWAY, BUT NOT THE ALTERNATIVE-PATHWAY, C-3 CONVERTASE
STRUNK, RC
WEBSTER, RO
MOLECULAR IMMUNOLOGY, 1985, 22 (01) : 37 - 43
[40] Decay acceleration of the complement alternative pathway C3 convertase
Hourcade, DE
Mitchell, LM
Medof, ME
IMMUNOPHARMACOLOGY, 1999, 42 (1-3): : 167 - 173

← 1 2 3 4 5 →